Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer

This study is currently recruiting participants.

Study NCT00515866 Information provided by AstraZeneca

First Received: August 13, 2007 Last Updated: September 22, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	August 2010
Estimated Primary Completion Date:	No date given